ID
32056
Descripción
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334?term=NCT00139334&rank=1 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form contains the trial's Eligibility Criteria. To be filled in at visit 1, prior to any study procedures. Timing: Day 0 Age: 6 weeks +/- 1 day
Link
https://clinicaltrials.gov/ct2/show/NCT00139334?term=NCT00139334&rank=1
Palabras clave
Versiones (2)
- 16/10/18 16/10/18 - Sarah Riepenhausen
- 16/10/18 16/10/18 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
16 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK oral HRV vaccine given with OPV in infants NCT00139334
Eligibility Criteria
- StudyEvent: ODM
Descripción
Eligibility Check
Alias
- UMLS CUI-1
- C0013893
Descripción
Inclusion criteria
Alias
- UMLS CUI-1
- C1512693
Descripción
Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol (e.g., completion of the diary cards, return for follow-up visits) should be enrolled in the study. (1)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0030551
Descripción
A male or female between, and including, 6 weeks +/- 1 week of age at the tiem of Visit 1. (2)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0001779
Descripción
Written informed consent obtained from the parent or guardian of the subject. (3)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021430
Descripción
Free of obvious health problems as established by medical history and clinical examination before entering into the study. (4)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1446390
Descripción
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Descripción
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period. (5)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0013230
Descripción
Planned administration of a vaccine not foreseen by the study protocol within 14 days before each dose of study vaccine(s) and ending 14 days after. (6)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0042196
Descripción
Chronic administration (defined as more than 14 days) of major immunosuppressants (equivalent to prednisone 1mg/kg/day) since birth. (Topical steroids are allowed.) (7)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C2347852
Descripción
Malnutrition (< 3Z score weight for age). (8)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0162429
Descripción
History of/or intercurrent polio disease. (9)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0032371
Descripción
Previous confirmed occurrence of RV GE. (10)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0017160
- UMLS CUI [1,2]
- C0035870
Descripción
History of use of experimental RV vaccine. (11)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0597418
Descripción
Previous routine vaccination except BCG, HBV and OPV vaccination at birth (should be documented in the CRF). (12)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0042196
- UMLS CUI [1,2]
- C0679831
Descripción
Any clinically significant history of chronic gastrointestinal disease including any uncorrected congenital malformation of the gastrointestinal tract, intussusception or other medical condition determined to be serious by the investigator. (13)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0017178
- UMLS CUI [2,1]
- C4023588
- UMLS CUI [2,2]
- C4072785
- UMLS CUI [3,1]
- C3843040
- UMLS CUI [3,2]
- C0205404
Descripción
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection. (14)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3829792
- UMLS CUI [2]
- C4048329
- UMLS CUI [3]
- C0019693
Descripción
History of allergic disease or reaction likely to be exacerbated by any component of the vaccine. (15)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2106654
Descripción
Acute disease at the time of enrolment. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as mild upper respiratory infection with or without low- grade febrile illness, i.e. Oral temperature <37.5°C (99.5°F) / Axillary temperature <37.5°C (99.5°F) / Rectal temperature <38°C (100.4°F).) (16)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0001314
Descripción
A family history of congenital or hereditary immunodeficiency. (17)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0241889
- UMLS CUI [1,2]
- C0853602
- UMLS CUI [2,1]
- C0241889
- UMLS CUI [2,2]
- C0439660
- UMLS CUI [2,3]
- C0021051
Descripción
Administration of immunoglobulins and/or blood products since birth or planned administration during the study period. (18)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021027
- UMLS CUI [2]
- C0456388
Descripción
History of any neurologic disorders or seizures. (19)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0027765
- UMLS CUI [2]
- C0036572
Descripción
Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests. (20)
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0231921
- UMLS CUI [2]
- C0678859
- UMLS CUI [3]
- C0232804
- UMLS CUI [4]
- C0232741
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0030551 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0035870 (UMLS CUI [1,2])
C0597418 (UMLS CUI [1,2])
C0679831 (UMLS CUI [1,2])
C4023588 (UMLS CUI [2,1])
C4072785 (UMLS CUI [2,2])
C3843040 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C4048329 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
C0853602 (UMLS CUI [1,2])
C0241889 (UMLS CUI [2,1])
C0439660 (UMLS CUI [2,2])
C0021051 (UMLS CUI [2,3])
C0456388 (UMLS CUI [2])
C0036572 (UMLS CUI [2])
C0678859 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [4])